Authors
Lauren E.W. Olsho, PhD, Laura J. Edwards, MPH, Brian Sokol, MSPA, Abt Global; Sarang K. Yoon, DO, MOH, Kurt T. Hegmann, MD, MPH, Matthew S. Thiese, PhD, MSPH, University of Utah Health; Jefferey L. Burgess, MD, MS, MPH, Katherine Ellingson, PhD, Karen Lutrick, PhD, University of Arizona; Alberto J. Caban-Martinez, DO, PhD, Natasha Schaefer Solle, PhD, John M. Jones, B.S., University of Miami; Harmony Tyner, MD, St. Luke’s Regional Health Care System (Duluth, MN); Manjusha Gaglani, MBBS, Kayan Dunnigan, MPH Spencer Rose, B.S. Baylor Scott & White Health; Allison Naleway, PhD, Holly Groom, MPH, Jennifer Kuntz, PhD, Kaiser Permanente Northwest; Ashley L. Fowlkes, ScD, Mark G. Thompson, PhD, Young M. Yoo, MSPH, Centers for Disease Control and Prevention (CDC)
In a letter to the editor of the New England Journal of Medicine, researchers from Abt Global and their partners reported that a study of essential and frontline workers showed that three doses of COVID-19 vaccine are more effective than two. The vaccines are less effective against Omicron than against the Delta variant but are effective against both.
The study for the Centers for Disease Control and Prevention (CDC) involved 3,241 essential and frontline workers who sent in nasal swabs weekly from August 26, 2021 until January 22, 2022, regardless of whether they had symptoms. Effectiveness against the Delta variant was 65 percent after two doses and 91 percent after three. The results were similar to a study in which participants received medical care because they had symptoms.
Vaccine effectiveness against Omicron infection for three doses (60 percent) was higher than for two doses (46 percent), but still substantially lower than three-dose effectiveness against Omicron reported elsewhere where individuals sought medical attention for their symptoms (82-90 percent). Lower effectiveness against mild or asymptomatic Omicron infection dovetails with data suggesting the Omicron variant is less severe. The results show continued effectiveness against clinically severe outcomes related to both variants.
The authors’ findings and conclusions do not necessarily represent the CDC’s views.
Read More
COVID-19 in North America
Healthy Military Families Undergird National Readiness
The only DoW-wide longitudinal study on U.S. military family health has generated vital evidence to inform programs, policies, and support services critical to family stability and force readiness.
Closing the Gap: Surveying LA Renters to Improve Housing Access
Abt helped HACLA collect and analyze current Los Angeles rental data, showing rents were about 12% higher than federal estimates and providing evidence to support voucher subsidy levels that better reflect local housing costs and improve access to stable housing.
Regulating Harmful Contaminants for Healthier Communities
Abt supported the EPA in developing and implementing data-driven regulations for hazardous chemicals—particularly carbon tetrachloride—helping turn scientific evidence into enforceable protections that reduce risks to workers, nearby communities, and the environment.
From Exposure to Protection: Securing Safe Drinking Water
Abt helped the EPA develop data-driven regulations, treatment tools, and exposure models that strengthen protections against contaminants such as PFAS and lead, improving drinking water safety for millions of Americans.